Trinity Biotech (TRIB) Net Income (2009 - 2024)

Trinity Biotech (TRIB) has reported Net Income for 16 consecutive years, with -$17.0 million the latest figure, recorded in Q4 2024.

• Quarterly Net Income fell 208.16% year-over-year to -$17.0 million in Q4 2024, while the trailing twelve-month figure through Dec 2025 was -$21.8 million (up 31.9% YoY) and the FY2025 annual result came in at -$37.4 million, down 17.58% from the prior year.
• Net Income declined to -$17.0 million in Q4 2024 per TRIB's latest filing, from -$4.8 million in the prior quarter.
• Over the last five years, Net Income for TRIB reached as high as $12.4 million in Q2 2023 and fell as low as -$17.0 million in Q4 2024.
• A 5-year average of -$2.3 million and a median of -$27000.0 in 2021 frame the typical range for Net Income.
• Annual changes were most pronounced in 2022 — Net Income slumped 40220.0% — and 2023, when it jumped 2899.51%.
• Year by year, Net Income stood at -$15.0 million in 2020, then jumped by 99.83% to -$25000.0 in 2021, then sank by 40220.0% to -$10.1 million in 2022, then jumped by 45.42% to -$5.5 million in 2023, then slumped by 208.16% to -$17.0 million in 2024.
• According to Business Quant data, Net Income over the past three periods registered -$17.0 million, -$4.8 million, and -$7.0 million for Q4 2024, Q3 2024, and Q2 2024 respectively.